TRPC1 and cancer: TRPC1 is a potential regulator of store-operated Ca2+ entry (SOCE) pathways [11] and has shown to be a potential biomarker of different cancer types, as its dysregulation correlates with several clinical parameters, including overall survival [12,13,14,15,16,17,18,19,20,21].